Many people might say that all press is good press, but it’s probably safe to say that Johnson & Johnson (JNJ) doesn’t agree. A multipart Huffington Post piece ripped the pharma company for covering up negative …
Investor Place · 9/25/2015
Johnson Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (Symbol: JNJ). So this week we highlight one interesting put contract, and …
NASDAQ · 9/28/2015
Johnson & Johnson (NYSE:JNJ) has earned an “AAA” credit rating from analysts at Morningstar. The firm’s “AAA” rating suggests that the company is an extremely-low default risk. They also gave their stock a four …
Ticker Report · 5 hours ago
Johnson Johnson
In-depth coverage >
More from Bing News
I recently added to my position in Emerson Electric (NYSE:EMR) and Johnson & Johnson (NYSE:JNJ). I was considering numerous other industrial positions. Eric Landis has been writing an excellent series of articles …
Seeking Alpha · 10/3/2015
Dow Jones component Johnson & Johnson (JNJ) saw its stock move -1.41% to $93.42, representing a per-share move of $1.34, on volume of 8.25 million shares for Tuesday. Johnson & Johnson currently has a total float of 2.77 billion shares and moves n/a …
Equities · 20 hours ago
Johnson Johnson
Johnson & Johnson (NYSE:JNJ), Merck (NYSE:MRK) and Boeing (NYSE:BA) were early leaders in the Dow. NYSE volume was tracking higher than Tuesday's level in the stock market today. Nasdaq volume was tracking close to Tuesday's level. Adobe …
Investors Business Daily · 1 hour ago
When done correctly, investing in the healthcare sector can yield impressive returns. But before you start buying stock in Johnson & Johnson (JNJ) or Aetna Inc. (AET), you need to educate yourself on the healthcare …
GoBankingRates · 10/2/2015
JNJ stock has shed 11% so far in 2015, while the NYSE ARCA Pharmaceutical Index has declined 4.33% in the same timeframe. The stock’s weak performance can be associated with greater competition in the … · 9/30/2015
Johnson & Johnson (NYSE: JNJ) is now officially out of the heart products business ... Don't be late to the party -- click here for one stock to own when the Web goes dark. Eric Volkman has no position in any stocks
Investopedia · 1 day ago
Johnson Johnson
Johnson & Johnson (NYSE:JNJ) was downgraded by Zacks from a “buy” rating to a “hold” rating in a research report issued on Tuesday, reports. According to Zacks, “Johnson & Johnson beat earnings expectations yet again in the … · 10/1/2015